Sign In
Buy ARDS
$0.0001
+0 (+0%)
At Close: Jul 31, 2026
The Daily Biotech Pulse: Canadian Approval For Amarin's Vascepa, Innate Pharma's Blood Cancer Drug Accepted For Review In Europe
01:46pm, Thursday, 02'nd Jan 2020
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Dec. 31.) Aptose Biosciences Inc (NASDAQ: APT
Aridis Pharmaceuticals Appoints Michael A. Nazak as Chief Financial Officer
10:30am, Thursday, 02'nd Jan 2020
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of targeted immunotherapies using fully human monoclonal antibodies (mAbs) to treat li
Aridis Pharmaceuticals Announces Third Quarter 2019 Results
09:05pm, Wednesday, 13'th Nov 2019
SAN JOSE, Calif. , Nov. 13, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of targeted immunotherapies using f
Introducing Aridis Pharmaceuticals (NASDAQ:ARDS), The Stock That Slid 52% In The Last Year
12:47pm, Saturday, 19'th Oct 2019
The nature of investing is that you win some, and you lose some. Unfortunately, shareholders of Aridis...
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical Officer
09:30am, Friday, 11'th Oct 2019
SAN JOSE, Calif. , Oct. 11, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies t
SAN JOSE, Calif., Sept. 30, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat l
Augmented reality: a vision for the future of manufacturing
11:56pm, Tuesday, 21'st Aug 2018
Augmented reality's potential to transform manufacturing is undeniable - but how close are we to AR being widely adopted?
